Rhythm Pharmaceuticals Inc.

NASDAQ:RYTM   3:59:55 PM EDT
24.80
-1.65 (-6.24%)
Other Pre-Announcement

Rhythm Pharmaceuticals Reports Second Quarter 2022 Financial Results And Business Update

Published: 08/02/2022 11:41 GMT
Rhythm Pharmaceuticals Inc. (RYTM) - Rhythm Pharmaceuticals Reports Second Quarter 2022 Financial Results and Business Update.
Rhythm Pharmaceuticals- Sees Existing Cash, Equivalents As of June 30, 2022 Will Be Sufficient to Fund Operations Into 2024.
As of June 30, 2022, Cash, Equivalents Were Approximately $235.6 Million.
Qtrly Loss per Share $0.89.
Q2 Earnings per Share View $-0.95 -- Refinitiv Ibes Data (analyst estimates).